George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,170.00
Ask: 12,172.00
Change: 182.00 (1.52%)
Spread: 2.00 (0.016%)
Open: 12,254.00
High: 12,256.00
Low: 12,052.00
Prev. Close: 11,988.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Barclays Cuts Travis Perkins To Underweight

Thu, 11th Aug 2016 08:35

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
BARCLAYS CUTS TRAVIS PERKINS TO 'UNDERWEIGHT' ('EQUALWEIGHT') - TARGET 1400 (1950) PENCE
----------
LIBERUM ADDS BRITISH LAND TO 'CONVICTION SELL LIST'
----------
COMMERZBANK CUTS EASYJET PRICE TARGET TO 1200 (1350) PENCE - 'HOLD'
----------
JPMORGAN CUTS RBS PRICE TARGET TO 175 (185) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN CUTS LLOYDS PRICE TARGET TO 62 (65) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BARCLAYS PRICE TARGET TO 175 (180) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ROLLS ROYCE GROUP PRICE TARGET TO 835 (730) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES PEARSON PRICE TARGET TO 935 (905) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BHP BILLITON PRICE TARGET TO 900 (885) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1378 (1324) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 5600 (5400) PENCE - 'BUY'
----------
HSBC CUTS ASTRAZENECA PRICE TARGET TO 4700 (4815) PENCE - 'HOLD'
----------
FTSE 250
----------
LIBERUM REMOVES TULLOW OIL FROM 'CONVICTION SELL LIST'
----------
PANMURE CUTS CENTAMIN TO 'HOLD' ('BUY') - TARGET 168 (145) PENCE
----------
RBC CAPITAL RAISES CENTAMIN PRICE TARGET TO 190 (170) PENCE - 'SECTOR PERFORM'
----------
Numis Ups Centamin Target To 180p From 160p, Keeps Hold
----------
HSBC RAISES SEGRO PRICE TARGET TO 418 (378) PENCE - 'HOLD'
----------
HSBC CUTS BRITVIC PRICE TARGET TO 620 (640) PENCE - 'HOLD'
----------
Investec Ups Virgin Money Target To 375p From 360p, Keeps Buy
----------
Cantor Cuts Debenhams Target To 60p From 70p, Keeps Hold
----------
Liberum Ups Spirax-Sarco Target To 4,090p From 3,140p, Keeps Hold
----------
MORGAN STANLEY RAISES SPIRAX-SARCO TARGET TO 4080 (3570) PENCE - 'EQUAL-WEIGHT'
----------
S&P GLOBAL RAISES AMEC PRICE TARGET TO 600 (500) PENCE - 'BUY'
----------
TRADERS: CANACCORD CUTS ENTERTAINMENT ONE TO 'HOLD' ('BUY')
----------
BERENBERG RAISES INMARSAT PRICE TARGET TO 910 (880) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
RBC CAPITAL CUTS FAROE PETROLEUM PRICE TARGET TO 100 (120) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES INTERSERVE PRICE TARGET TO 425 (416) PENCE - 'OVERWEIGHT'
----------
finnCap Initiates Joules Group With Buy, Target At 200p
----------
Berenberg Ups Benchmark Holdings Target To 80p From 70p, Keeps Buy
----------
BERENBERG RAISES STOCK SPIRITS PRICE TARGET TO 150 (137) PENCE - 'HOLD'
----------
BERENBERG CUTS LOOKERS PRICE TARGET TO 170 (220) PENCE - 'BUY'
----------
BERENBERG RAISES GVC HOLDING PRICE TARGET TO 760 (730) PENCE - 'BUY'
----------
BERENBERG RAISES STAFFLINE TO 'BUY' ('HOLD') - TARGET 1250 (900) PENCE
----------
Numis Ups Breedon Aggregates to Add From Hold, Target To 82p From 70p
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.